Literature DB >> 26372187

Bypass surgery versus endovascular interventions in severe or critical limb ischemia.

Abd Moain Abu Dabrh1, Mark W Steffen2, Noor Asi3, Chaitanya Undavalli3, Zhen Wang3, Mohamed B Elamin3, Michael S Conte4, Mohammad Hassan Murad5.   

Abstract

OBJECTIVE: Critical limb ischemia is associated with a significant morbidity and mortality. We systematically reviewed the evidence to compare bypass surgery with endovascular revascularization in patients with critical limb ischemia.
METHODS: We systematically searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials, CINAHL, and Scopus through October 2014 for comparative studies (randomized and nonrandomized). Predefined outcomes of interest were mortality, major amputation, patency, and wound healing. We pooled odds ratios (ORs) of the outcomes of interest using the random-effects model.
RESULTS: Nine studies that enrolled 3071 subjects were included. There was no significant difference in mortality (OR, 0.72; 95% confidence interval [CI], 0.44-1.16) or amputation (OR, 1.2; 95% CI, 0.87-1.65). Bypass surgery was associated with higher primary patency (OR, 2.50; 95% CI, 1.25-4.99) and assisted primary patency (OR, 3.39; 95% CI, 1.53-7.51). The quality of evidence was low for mortality and amputation outcomes and moderate for patency outcomes.
CONCLUSIONS: Low quality of evidence due to imprecision and heterogeneity suggests that bypass surgery and endovascular approaches may have similar effect on mortality and major amputations. However, better primary and primary assisted patency can be expected with surgery.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26372187     DOI: 10.1016/j.jvs.2015.07.068

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  14 in total

Review 1.  Current Status of Arterial Revascularization for the Treatment of Critical Limb Ischemia in Infrainguinal Atherosclerotic Disease.

Authors:  Ahmet Yuksel; Yusuf Velioglu; Mustafa Cagdas Cayir; Gencehan Kumtepe; Orcun Gurbuz
Journal:  Int J Angiol       Date:  2018-01-22

2.  Comparison of perfusion values after percutaneous transluminal angioplasty according to the severity of ischaemia in the diabetic foot.

Authors:  Sik Namgoong; Jong-Phil Yang; Ki-Hyun Yoo; Seung-Kyu Han; Seung-Woon Rha; Ye-Na Lee
Journal:  Int Wound J       Date:  2018-10-12       Impact factor: 3.315

Review 3.  Bypass surgery for chronic lower limb ischaemia.

Authors:  George A Antoniou; George S Georgiadis; Stavros A Antoniou; Ragai R Makar; Jonathan D Smout; Francesco Torella
Journal:  Cochrane Database Syst Rev       Date:  2017-04-03

Review 4.  Prioritizing Functional Capacity as a Principal End Point for Therapies Oriented to Older Adults With Cardiovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Authors:  Daniel E Forman; Ross Arena; Rebecca Boxer; Mary A Dolansky; Janice J Eng; Jerome L Fleg; Mark Haykowsky; Arshad Jahangir; Leonard A Kaminsky; Dalane W Kitzman; Eldrin F Lewis; Jonathan Myers; Gordon R Reeves; Win-Kuang Shen
Journal:  Circulation       Date:  2017-03-23       Impact factor: 29.690

5.  Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee.

Authors:  Maria Teresa B Abola; Jonathan Golledge; Tetsuro Miyata; Seung-Woon Rha; Bryan P Yan; Timothy C Dy; Marie Simonette V Ganzon; Pankaj Kumar Handa; Salim Harris; Jiang Zhisheng; Ramakrishna Pinjala; Peter Ashley Robless; Hiroyoshi Yokoi; Elaine B Alajar; April Ann Bermudez-Delos Santos; Elmer Jasper B Llanes; Gay Marjorie Obrado-Nabablit; Noemi S Pestaño; Felix Eduardo Punzalan; Bernadette Tumanan-Mendoza
Journal:  J Atheroscler Thromb       Date:  2020-07-04       Impact factor: 4.928

Review 6.  Peripheral arterial disease: Scoping review of patient-centred outcomes.

Authors:  Laura Bolton
Journal:  Int Wound J       Date:  2019-10-09       Impact factor: 3.315

7.  Extensive skeletal muscle cell mitochondriopathy distinguishes critical limb ischemia patients from claudicants.

Authors:  Terence E Ryan; Dean J Yamaguchi; Cameron A Schmidt; Tonya N Zeczycki; Saame Raza Shaikh; Patricia Brophy; Thomas D Green; Michael D Tarpey; Reema Karnekar; Emma J Goldberg; Genevieve C Sparagna; Maria J Torres; Brian H Annex; P Darrell Neufer; Espen E Spangenburg; Joseph M McClung
Journal:  JCI Insight       Date:  2018-11-02

Review 8.  "Modern Endovascular Therapy".

Authors:  Matthew Blecha; Vivian Gahtan
Journal:  World J Surg       Date:  2020-11-22       Impact factor: 3.352

Review 9.  Critical Limb Ischemia: Current Trends and Future Directions.

Authors:  Martin Teraa; Michael S Conte; Frans L Moll; Marianne C Verhaar
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

10.  Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.

Authors:  Michel M P J Reijnen; Iris van Wijck; Thomas Zeller; Antonio Micari; Pierfrancesco Veroux; Koen Keirse; Seung-Whan Lee; Pei Li; Despina Voulgaraki; Suzanne Holewijn
Journal:  J Endovasc Ther       Date:  2019-04-01       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.